AGI.do

Products

What will AGI do for Acetorphine?

This classification denotes an analgesic agent with the molecular formula C27H35NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2OGQ81529L, chemically known as 6,7,8,14-tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine 3-acetate but generally known as acetorphine, which bears US NIH Compound Identifier 62795. European Medicines Agency schedules Acetorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05226MIG. The term ACETORPHINE is an International Non-Proprietary Name. ACETORPHINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acetorphine under HS 29391900 and SITC 54141. As of Q4 2014, ACETORPHINE remains the US FDA Preferred Term for this commodity. Acetorphine bears US NLM identifiers UMLS ID C2699531 and NCI Concept Code C79929. SMILES: O1C2C34C5(C(N(CC3)C)CC3C4C1C(OC(=O)C)CC3)CC(C2(OC)C=C5)C(O)(CCC)C.

How AGI delivers it

Four ways AGI delivers for Acetorphine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Acetorphine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Acetorphine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Acetorphine connects

measured by

  • Assaymodel
  • Chemical Assay Puritymodel
  • Optical Rotationmodel
  • Potencymodel
  • Puritymodel
  • Related Substances Contentmodel
  • Residual Solvent Contentmodel

Go deeper

Explore Acetorphine

Read the deeper take on agi.asView as markdown